RT @Janetbirdope: JAK will quiet Stillâs disease? 7 w Stillâs 4 refractory disease had benefit w #JAKi POS0014. Need
Tweet Content
JAK will quiet Still’s disease? 7 w Still’s 4 refractory disease had benefit w #JAKi POS0014. Needs more data but looks promising most w partial response . 5 on #Tofacitinib and 2 w #Baricitinib. @eular_org #EULAR2022 POS0014 @RheumNow https://t.co/j9IRgT9XJf
Show on Archive Page
On
Display in Search Results
On
PDQ
Off